Iron-deficiency Clinical Trial
Official title:
The Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores: Determination of a Dose-dependent Effect of Galacto-oligosaccharides on Iron Absorption, With and Without Addition of Ascorbic Acid
Iron deficiency is still the most common and widespread nutritional disorder in the world
according to WHO.
In a recent iron absorption study in adult women with low iron stores in our lab (publication
under review), we found that 15 g of GOS given with an iron supplement in the form of iron
fumarate acutely increased iron absorption when given with water and a bread based meal. The
dose of 15 g of GOS was tolerated well by the participants. As a follow up to the study
mentioned above, we want to investigate: 1) if acute iron absorption is affected by lower
doses of GOS; 2) whether this acute effect occurs for other commonly used iron compounds as
well, such as iron sulphate and iron phosphate; and 3) if there are potential interactions on
absorption with other enhancers of iron absorption, such as vitamin c.
Iron is an important mineral in our body and fulfills essential functions such as for example
oxygen transport from the lungs to the tissues. Iron deficiency is still the most common and
widespread nutritional disorder in the world according to WHO. Common iron supplements all
have their limitations in terms of availability and compatibility. Prebiotic fibers, such as
galacto-oligosaccharides (GOS), selectively enhance growth of beneficial colonic bacteria.
Prebiotics in general enhance the production of short-chain fatty acids (SCFAs) and thereby
decrease luminal pH. Through the reduction in pH, prebiotics can enhance absorption of
minerals such as calcium and magnesium and they have been proposed to potentially improve
iron absorption.
In a recent iron absorption study in adult women with low iron stores in our lab (publication
under review), we found that 15 g of GOS given with an iron supplement in the form of iron
fumarate acutely increased iron absorption when given with water and a bread based meal. The
dose of 15 g of GOS was tolerated well by the participants. As a follow up to the study
mentioned above, we want to investigate: 1) if acute iron absorption is affected by lower
doses of GOS; 2) whether this acute effect occurs for other commonly used iron compounds as
well, such as iron sulphate and iron phosphate; and 3) if there are potential interactions on
absorption with other enhancers of iron absorption, such as vitamin c.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
Terminated |
NCT03218384 -
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
|
Phase 2 | |
Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
Completed |
NCT03572010 -
Stable Iron Isotope Method in HIV+ and HIV- Children
|
N/A | |
Active, not recruiting |
NCT03703726 -
Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Not yet recruiting |
NCT05395468 -
Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
|
||
Withdrawn |
NCT03800446 -
Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood
|
N/A | |
Not yet recruiting |
NCT03353662 -
Sub Regional Micronutrient Survey in Ethiopia
|
||
Completed |
NCT03819530 -
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
|
N/A | |
Recruiting |
NCT04144790 -
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
|
||
Completed |
NCT03957057 -
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
|
Phase 3 | |
Completed |
NCT03642223 -
Central and Peripheral Adiposity and Iron Absorption
|
N/A | |
Not yet recruiting |
NCT05407987 -
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
|
Phase 3 | |
Withdrawn |
NCT03873584 -
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
|
||
Enrolling by invitation |
NCT03897673 -
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
|
N/A | |
Completed |
NCT04359368 -
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
|
||
Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
Enrolling by invitation |
NCT05750940 -
Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
|
||
Recruiting |
NCT05126901 -
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
|
Phase 3 |